Literature DB >> 23684149

Laparoscopic Heller's myotomy versus pneumatic dilation in the treatment of idiopathic achalasia: a meta-analysis of randomized, controlled trials.

Mohammad Yaghoobi1, Serge Mayrand, Myriam Martel, Ira Roshan-Afshar, Raheleh Bijarchi, Alan Barkun.   

Abstract

BACKGROUND: Pneumatic dilation (PD) and laparoscopic Heller's myotomy (LHM) are the mainstays of therapy in idiopathic achalasia. Equipoise exists in choosing the first-line therapy.
OBJECTIVE: To assess comparative efficacies and adverse event rates of these methods.
DESIGN: Intention-to-treat, fixed-model, Mantel-Haenszel meta-analysis of randomized, controlled trials comparing PD with LHM.
SETTING: Randomized controlled trial comparing PD versus LHM. PATIENTS: Patients with newly diagnosed idiopathic achalasia. INTERVENTION: Comprehensive electronic and manual literature search from 1966 to March 2012 independently by two reviewers. MAIN OUTCOME MEASUREMENTS: Response rate, rate of different adverse events, and quality of life after each therapy.
RESULTS: Three of 161 retrieved studies between 2007 and 2011, including 346 patients, were included. At 1 year, the cumulative response rate was significantly higher with LHM (86% vs 76%, odds ratio 1.98 (confidence interval 1.14-3.45); P = .02), with no significant heterogeneity (P = .39; I(2) 0%). Rates of major mucosal tears requiring subsequent intervention with LHM were significantly lower than those of esophageal perforation with PD requiring postprocedural medical or surgical therapy (0.6% and 4.8%, respectively; P = .04). Postprocedural rates of gastroesophageal reflux, lower esophageal sphincter pressures, and quality of life scores did not differ in trials with sufficient data. Data on longer follow-up were not available. LIMITATIONS: Lack of data on follow-ups over 1 year and a small number of included studies.
CONCLUSION: This meta-analysis suggests that LHM may provide greater response rates as compared with graded PD in the treatment of newly diagnosed idiopathic achalasia, with lesser rates of major adverse events, in up to 1 year after treatment, although additional data are needed to confirm the validity of this conclusion in long-term follow-up.
Copyright © 2013 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  European Organisation for Research and Treatment of Cancer disease-specific questionnaire module; GER; LES; LHM; Medical Outcomes Study 36-item short-form health survey; PD; QLQ-OES24; SF-36; gastroesophageal reflux; laparoscopic Heller's myotomy; lower esophageal sphincter; pneumatic dilation

Mesh:

Year:  2013        PMID: 23684149     DOI: 10.1016/j.gie.2013.03.1335

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  47 in total

1.  Systematic review and meta-analysis: Efficacy and safety of POEM for achalasia.

Authors:  Lavinia A Barbieri; Cesare Hassan; Riccardo Rosati; Uberto Fumagalli Romario; Loredana Correale; Alessandro Repici
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

Review 2.  Achalasia: current therapeutic options.

Authors:  Zubin Arora; Prashanthi N Thota; Madhusudhan R Sanaka
Journal:  Ther Adv Chronic Dis       Date:  2017-06-23       Impact factor: 5.091

3.  Laparoscopic Heller's Myotomy for Achalasia Cardia: One-Time Treatment in Developing Countries?

Authors:  Vishal Gupta; Hunaid Hatimi; Saket Kumar; Abhijit Chandra
Journal:  Indian J Surg       Date:  2016-05-24       Impact factor: 0.656

4.  An extended proximal esophageal myotomy is necessary to normalize EGJ distensibility during Heller myotomy for achalasia, but not POEM.

Authors:  Ezra N Teitelbaum; Nathaniel J Soper; John E Pandolfino; Peter J Kahrilas; Lubomyr Boris; Frédéric Nicodème; Zhiyue Lin; Eric S Hungness
Journal:  Surg Endosc       Date:  2014-05-23       Impact factor: 4.584

5.  Treatment of esophageal motility disorders based on the chicago classification.

Authors:  Carla Maradey-Romero; Scott Gabbard; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2014-12

6.  Prior treatment does not influence the performance or early outcome of per-oral endoscopic myotomy for achalasia.

Authors:  Edward L Jones; Michael P Meara; Matthew R Pittman; Jeffrey W Hazey; Kyle A Perry
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

7.  Anterior Dor or Posterior Toupet with Heller Myotomy for Achalasia Cardia: A Systematic Review and Meta-Analysis.

Authors:  Manjunath Siddaiah-Subramanya; Rossita Mohamad Yunus; Shahjahan Khan; Breda Memon; Muhammed Ashraf Memon
Journal:  World J Surg       Date:  2019-06       Impact factor: 3.352

8.  Clinical outcomes five years after POEM for treatment of primary esophageal motility disorders.

Authors:  Ezra N Teitelbaum; Christy M Dunst; Kevin M Reavis; Ahmed M Sharata; Marc A Ward; Steven R DeMeester; Lee L Swanström
Journal:  Surg Endosc       Date:  2017-06-29       Impact factor: 4.584

9.  Symptomatic and physiologic outcomes one year after peroral esophageal myotomy (POEM) for treatment of achalasia.

Authors:  Ezra N Teitelbaum; Nathaniel J Soper; Byron F Santos; Fahd O Arafat; John E Pandolfino; Peter J Kahrilas; Ikuo Hirano; Eric S Hungness
Journal:  Surg Endosc       Date:  2014-06-18       Impact factor: 4.584

10.  Early clinical experience with the POEM procedure for achalasia.

Authors:  Dennis Hong; Radu Pescarus; Rana Khan; Luciano Ambrosini; Mehran Anvari; Margherita Cadeddu
Journal:  Can J Surg       Date:  2015-12       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.